Tiny sensors could revolutionize jaundice treatment for newborns

NCT ID NCT07057635

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new wireless sensor that continuously measures the light dose babies receive during phototherapy for jaundice. Currently, doctors check light levels only once a day with a handheld device, which can be inaccurate. The sensor aims to provide real-time data to ensure babies get the right amount of treatment. Nine newborns in the NICU will be enrolled to compare the sensor's readings with standard measurements.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
wireless irradiance sensor (bilisensor)
What this could lead to
If successful, this could lead to better, real-time monitoring of phototherapy for newborns with jaundice, potentially improving treatment accuracy.
What could go wrong
This is a very small, early-stage study with only 9 participants, so results may not apply broadly. The device may have data gaps or accuracy issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JAUNDICE, NEONATAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Montreal Children's Hospital

    Montreal, Quebec, H4A 3H9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.